CPC Subgroup Additional Only
A61K 2239/46 characterised by the cancer treated
Full Title
Indexing codes associated with cellular immunotherapy of group A61K40/00 > characterised by the cancer treated
13 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- A61K 2239/47 Brain; Nervous system
- A61K 2239/48 Blood cells, e.g. leukemia or lymphoma
- A61K 2239/49 Breast
- A61K 2239/50 Colon
- A61K 2239/51 Stomach
- A61K 2239/52 Intestine
- A61K 2239/53 Liver
- A61K 2239/54 Pancreas
- A61K 2239/55 Lung
- A61K 2239/56 Kidney
- A61K 2239/57 Skin; melanoma
- A61K 2239/58 Prostate
- A61K 2239/59 Reproductive system, e.g. uterus, ovaries, cervix or testes
Top Applicants
Top 10 applicants by patent filingsfor class A61, 2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 20,621
- NOVARTIS CH 15,792
- ROCHE CH 14,303
- COVIDIEN US 13,862
- HARVARD UNIVERSITY US 13,454
- UNIVERSITY OF CALIFORNIA US 12,798
- P&G (PROCTER & GAMBLE COMPANY) US 12,140
- L'OREAL FR 11,800
- OLYMPUS CORPORATION JP 9,894
- BOSTON SCIENTIFIC SCIMED US 9,513